Data / Drug companies / Prodigy Media Inc
Prodigy Media Inc: 15 products in the FDA NDC directory, labeler code 70171
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Prodigy Media Inc (labeler code 70171) lists 15 products in the FDA National Drug Code Directory, covering 2 finished drugs by generic name. By type: 15 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on July 31, 2026.
The request: Watch Prodigy Media Inc (FDA labeler code 70171): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 70171
- Products in commercial distribution
- 15
- Packages
- 15
- Finished drugs by generic name
- 2
- Prescription products
- 0
- Over the counter products
- 15
- Flagged as original packager
- 15 of 15 products that carry the flag
- Started marketing in the last 12 months
- 5
- Earliest marketing start
- July 18, 2024
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 15 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 15 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Lidocaine hcl | 11 | 48 |
| Benzocaine | 4 | 110 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 14 | 93.3% |
| Spray | 1 | 6.7% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Amide Local Anesthetic | 11 |
| Antiarrhythmic | 11 |
| Standardized Chemical Allergen | 4 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Pure Primal Delay Cream | 70171-0061 | Cream | Over the counter monograph drugs | July 31, 2026 |
| Bravado Labs Delay Cream | 70171-0041 | Cream | Over the counter monograph drugs | June 20, 2026 |
| Do me delay | 70171-0051 | Cream | Over the counter monograph drugs | May 1, 2026 |
| Alphamale Delay Cream | 70171-0071 | Cream | Over the counter monograph drugs | January 20, 2026 |
| Do Me Delay Cream | 70171-0052 | Cream | Over the counter monograph drugs | January 20, 2026 |
| Bravado Labs Numbing | 70171-0400 | Spray | Over the counter monograph drugs | July 27, 2025 |
| Pure primal delay | 70171-0060 | Cream | Over the counter monograph drugs | July 27, 2025 |
| Ink Scribd Numbing | 70171-0029 | Cream | Over the counter monograph drugs | July 27, 2025 |
| Inkorporated Numbing | 70171-0028 | Cream | Over the counter monograph drugs | July 27, 2025 |
| InkKulture Numbing | 70171-0022 | Cream | Over the counter monograph drugs | July 27, 2025 |
| TattooGirl Numbing | 70171-0021 | Cream | Over the counter monograph drugs | July 27, 2025 |
| Dr Tatty Numbing | 70171-0020 | Cream | Over the counter monograph drugs | July 27, 2025 |
| Inked Inspired | 70171-0003 | Cream | Over the counter monograph drugs | July 27, 2025 |
| Dr Lido | 70171-0002 | Cream | Over the counter monograph drugs | July 11, 2025 |
| NumbR-X | 70171-0001 | Cream | Over the counter monograph drugs | July 18, 2024 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.